2010
DOI: 10.4172/1939-067x.1000127
|View full text |Cite
|
Sign up to set email alerts
|

Subarachnoid pharmacotherapy for maximizing recovery after cortical ischemic stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…Implants that do not penetrate the brain are in many cases preferable to brain‐penetrating ones, as the latter cause more tissue damage and increase risk for the patient. To that end, there have been multiple devices designed for drug delivery within the intracranial space between brain and skull including gels and tablets that release drugs as they dissolve and various systems that allow for fluidic injection of drugs . However, fluidic drug injection systems have been plagued by problems with clogging and reflux while the single‐use nature of dissolving implants is not well suited for the treatment of chronic disorders.…”
mentioning
confidence: 99%
“…Implants that do not penetrate the brain are in many cases preferable to brain‐penetrating ones, as the latter cause more tissue damage and increase risk for the patient. To that end, there have been multiple devices designed for drug delivery within the intracranial space between brain and skull including gels and tablets that release drugs as they dissolve and various systems that allow for fluidic injection of drugs . However, fluidic drug injection systems have been plagued by problems with clogging and reflux while the single‐use nature of dissolving implants is not well suited for the treatment of chronic disorders.…”
mentioning
confidence: 99%